Personalized Risk-Based Screening Design for Comparative Two-Arm Group Sequential Clinical Trials

Personalized medicine has been emerging to take into account individual variability in genes and environment. In the era of personalized medicine, it is critical to incorporate the patients’ characteristics and improve the clinical benefit for patients. The patients’ characteristics are incorporated...

Descripción completa

Detalles Bibliográficos
Autor principal: Park, Yeonhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953575/
https://www.ncbi.nlm.nih.gov/pubmed/35330448
http://dx.doi.org/10.3390/jpm12030448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953575/
https://www.ncbi.nlm.nih.gov/pubmed/35330448
http://dx.doi.org/10.3390/jpm12030448

Ejemplares similares